Regorafenib is a kinase inhibitor used for the treatment of patients with metastatic colorectal cancer (CRC) who have been already taken treatment with oxaliplatin and irinotecan-based chemo, an anti-VEGF therapy, and, an anti-EGFR therapy. The regorafenib price may vary depending on the brand and wholesaler/pharmacy you choose.
The recommended regorafenib dose is 160 mg regorafenib (4 regorafenib 40 mg tablets) is taken orally once daily at the same time each day. Swallow the tablet whole through a low-fat breakfast that contains less than 30% fat. Regorafenib treatment should be continued until the disease is progressive.